Pancreatic Cancer Research

ResearcherHarbin Medical UniversityActive in the last 2 years

Zhiwei Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0008-3278-1047; OpenAlex author ID A5061277017. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
5
Papers, trials and grants by year

2025: 1 paper · 2026: 2 papers

Papers 3

  1. USP15 Promotes Pancreatic Cancer Progression and Cisplatin Resistance By Activating DNA Damage Repair. Last author DOI 10.1002/mc.70105↗
  2. Dynamic Expression Quantitative Trait Locus Mendelian Randomization in Activated CD4-Positive T Cells Nominates SMDT1 and CMTM7 as Candidate Genes in Pancreati… Last author DOI 10.1002/mc.70198↗
  3. TRIM21 Promotes Tumor Growth and Gemcitabine Resistance in Pancreatic Cancer by Inhibiting EPHX1-Mediated Arachidonic Acid Metabolism. Last author DOI 10.1002/advs.202413674↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hengzhen Li · 2 shared papers, 2025–2026 · strength 0.48
  2. Haitao Wang · 1 shared paper, 2026 · strength 0.29
  3. Zhigang Ma · 1 shared paper, 2026 · strength 0.27
  4. Xiaona Fan · 1 shared paper, 2025 · strength 0.21
  5. Changjie Lou · 1 shared paper, 2025 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.